Home > Boards > US Listed > Medical - Drugs > Horizon Pharma, Inc. (HZNP)

Getting killed

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Cheds Member Profile
 
Followed By 1,142
Posts 29,347
Boards Moderated 1
Alias Born 01/02/14
160x600 placeholder
Horizon Therapeutics plc Donates Additional $1.2 Million to Support COVID-19 Relief Efforts in Illinois & Other Impacted U.S.... Business Wire - 11/30/2020 8:00:00 AM
Horizon Therapeutics plc to Participate in Upcoming Investor Conferences Business Wire - 11/25/2020 8:00:00 AM
Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Techn... PR Newswire (US) - 11/23/2020 8:00:00 AM
Horizon Therapeutics plc & Halozyme Therapeutics, Inc. Enter Global Collaboration & License Agreement for ENHANZE® Technology Business Wire - 11/23/2020 8:00:00 AM
National Association for Bus. Resources Names Horizon Therapeutics One of the Best & Brightest Companies to Work For in the N... Business Wire - 11/17/2020 9:15:00 AM
First Thyroid Eye Disease (TED) Awareness Week to Increase Education and Understanding of Vision-Threatening Disease Business Wire - 11/16/2020 10:54:00 AM
First Thyroid Eye Disease (TED) Awareness Week to Increase Education and Understanding of Vision-Threatening Disease Business Wire - 11/16/2020 8:00:00 AM
New Data Build on Growing Evidence Supporting TEPEZZA® (teprotumumab-trbw) Efficacy in Thyroid Eye Disease (TED), Including ... Business Wire - 11/13/2020 8:30:00 AM
Horizon Therapeutics plc CEO Tim Walbert Honored with RARE Champion Award at Global Genes Champions of Hope Gala Business Wire - 11/13/2020 8:00:00 AM
Horizon Therapeutics plc to Participate in Upcoming Investor Conferences Business Wire - 11/12/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/6/2020 6:01:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/6/2020 6:01:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/6/2020 6:01:07 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/3/2020 4:23:23 PM
Higher Response Rates in RECIPE Randomized Controlled Trial of KRYSTEXXA® (pegloticase injection) Concomitantly Used with th... Business Wire - 11/2/2020 2:00:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/2/2020 7:33:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2020 7:08:32 AM
Horizon Therapeutics plc Reports Record Third-Quarter 2020 Results; Increases TEPEZZA® Full-Year Net Sales Guidance to Great... Business Wire - 11/2/2020 7:00:00 AM
Horizon Therapeutics plc Names Karin Rosén, M.D., Ph.D. Executive Vice President, Research & Development & Chief Scientific ... Business Wire - 11/2/2020 6:58:00 AM
Chicago Tribune Names Horizon Therapeutics a 2020 Top Workplace for the Sixth Consecutive Year Business Wire - 10/30/2020 9:15:00 AM
New TEPEZZA® (teprotumumab-trbw) Data to Be Presented at the American Academy of Ophthalmology 2020 Annual Meeting Business Wire - 10/30/2020 8:00:00 AM
AGC Biologics and Horizon Therapeutics plc Expand Partnership PR Newswire (US) - 10/29/2020 3:00:00 PM
Horizon Therapeutics plc Initiates Clinical Trial to Assess Shorter Infusion Duration for KRYSTEXXA® (pegloticase injection)... Business Wire - 10/29/2020 8:00:00 AM
Horizon Therapeutics plc Named One of the Most Innovative Companies by Crain’s Chicago Business Business Wire - 10/26/2020 8:00:00 AM
Horizon Therapeutics plc Named One of the Best Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption Business Wire - 10/23/2020 8:00:00 AM
Cheds   Wednesday, 11/08/17 12:03:21 PM
Re: jtf3 post# 675
Post # of 689 
Getting killed

Helping new traders avoid my old mistakes #chedsblog
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences